Lantern Pharma Inc expected to post a loss of 56 cents a share - Earnings Preview

Lantern Pharma

06/11/2024 05:06

* Lantern Pharma Inc  LTRN.OQ   LTRN.O  is expected to show
no
change in quarterly revenue when it reports  results on November
7 for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Lantern Pharma Inc is
for a
loss of 56 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lantern
Pharma
Inc is 22.00​, above​ its last closing price of $3.27. ​​​

This summary was machine generated November 6 at 05:06 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)